New York, Global Rapid Microbiology Testing Market was valued at USD 4.2 billion in 2021 and it is anticipated to grow up to USD 10.7 billion by 2031, at a CAGR of 9.8% during the forecast period.
The global rapid microbiology testing market report from Global Insight Services is the single authoritative source of intelligence on Rapid Microbiology Testing Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Rapid microbiology testing has high sensitivity and less turnover time compared to traditional methods and is used to diagnose infectious diseases or target products by examining pathogens within a short period.
Request sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10356/
Market Trends and Drivers
Increasing incidence of infectious disease and cancer will drive the industry growth. The incidence of various infectious diseases such as HIV, tuberculosis, malaria, and pneumonia has increased. With a rise in the global burden of these diseases, the demand for rapid microbiology techniques for faster and accurate microbial screening, identification, and susceptibility testing against pathogens is expected to witness significant growth during the forecast period
Global Rapid Microbiology Testing Market Segmental Overview
The report analyses the global rapid microbiology testing market based on product, application, method, and region.
Global Rapid Microbiology Testing Market by Product
Based on product, it is segmented into instrument, reagent and kits, and consumables. Among these, the instruments segment is expected to witness significant CAGR through 2031. This is attributed to the adoption of new instruments with advanced technology. For instance, in August 2018, Illumina received approval from the China National Drug Administration for the launch of MiSeq Dx Sequencing System in China. The clinical laboratories can develop and perform next generation sequencing (NGS) tests for gene testing to determine the order of nucleotides in entire genome or targeted regions of DNA or RNA. Thus, patients and various medical institutions have increased access to next generation sequencing technology. Hence, with advanced technologies the demand of new instruments surges, thereby propelling the overall market expansion.
Global Rapid Microbiology Testing Market by Method
Based on method, it is segmented into growth-based rapid microbiology testing, cellular component-based rapid microbiology testing, nucleic acid-based rapid microbiology testing and viability-based rapid microbiology testing. Among them, the growth-based rapid microbiology testing segment accounted for USD 12.6 billion in 2021 as it offer a greater sensitivity. Factors such as increased focus on the early detection of infectious disease increased funding for R&D and increased incidence of infectious disease and cancer. Moreover, growth-based RMMs provide either a quantitative cell count, estimation of viable cell concentration, information regarding the presence of a specific microorganism, or a microbial identification. However, the ability of these RMM systems are limited in scope in that they cannot be used to perform multiple assays using a single technology platform.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10356/
Global Rapid Microbiology Testing Market by Application
Based on application, it is segmented into clinical disease diagnostics, food & beverage testing, pharmaceutical & biological drug testing, environmental testing, cosmetics and personal care products testing, research applications and others. In 2021, the clinical disease diagnostics segment accounted for the largest share of the rapid microbiology testing market. The increasing incidence of infectious disease and cancer is driving the growth of this segment. Clinical diagnosis made on the basis of medical signs and reported symptoms, rather than diagnostic tests. Moreover, the main clinical manifestations of COVID-19 include fever, cough, fatigue, headache, myalgia among other less frequent symptoms. However, the presentation of symptoms varies among children, young adult and the elderly.
Geographical Analysis of Global Rapid Microbiology Testing Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America therapeutic respiratory devices market captured significant market share in 2021 and is expected to grow significantly during the forecast years owing to the presence of sophisticated healthcare facilities in the U.S. and Canada. Also, the increasing healthcare expenditure due to rising awareness will augment the market share. Moreover, the increasing prevalence of COVID-19 infections along with rising healthcare spending is expected to boost the market outlook in the forthcoming years. For instance, according to the data published by USA Facts, there were 67,008 confirmed cases of COVID-19 infection on February 25, 2022. This number is increasing every day, thus increasing the demand for COVID-19 detection kits. All these factors along with the technological advancements in virus detection technologies increase the demand for COVID-19 detection kits, thereby propelling the regional market statistics.
Major Players in the Global Rapid Microbiology Testing Market
The key players in the market are Abbott Laboratories, Inc. (US), Becton, Dickinson and Company (US), bioMérieux SA (France), Bruker Corporation (US), Charles River Laboratories International, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), NEOGEN Corporation (US), Quidel Corporation (US), Sartorius AG (Germany) and Thermo Fisher Scientific, Inc. (US), among others.
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10356/
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700